
Prasad said the backward integration will allow Granules to mitigate supply chain disruptions, volatility in prices and also increase expectations of environmental standards. Granules will spend about ₹250 crore on its backward integration and ₹150 crore on its greenfield formulation manufacturing unit in Genome Valley, near Hyderabad.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IOVa87B
via
IFTTT
0 comments:
Post a Comment